Most Read Articles
2 days ago
There appears to be a high rate of emergency department (ED) admission for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), with patients having significant in-hospital mortality, according to data from the *AANZDEM study. Furthermore, compliance with evidence-based treatments in the ED is suboptimal.
Tristan Manalac, 6 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
Pearl Toh, 3 days ago
Patients with inflammatory bowel disease (IBD) who had primary nonresponse to an anti-tumour necrosis factor (TNF) agent ─ or inadequate response to the initial loading doses ─ were less likely to respond to second-line biologics compared with those who had secondary loss of response (LOR) or intolerance to the primary therapy, according to a systematic review and meta-analysis presented at the Crohn's & Colitis Congress (CCC) 2018 held recently in Las Vegas, Nevada, US.
Tristan Manalac, 16 Feb 2018
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.

Coffee is more beneficial than harmful to health, except during pregnancy

Stephen Padilla
06 Dec 2017
For pregnant women, limit coffee to 2 cups, but don't quit drinking altogether, obstetricians advise.

Coffee drinking appears to be generally safe within usual levels of intake and is more likely to benefit health than harm, except during pregnancy and in women at increased risk of fracture, according to the results of an umbrella review of meta-analysis of multiple health outcomes.

“Beneficial associations between coffee consumption and liver outcomes (fibrosis, cirrhosis, chronic liver disease and liver cancer) have relatively large and consistent effect sizes compared with other outcomes,” researchers said. “Consumption is also beneficially associated with a range of other health outcomes and importantly does not seem to have definitive harmful associations with any outcomes outside of pregnancy.”

After accessing PubMed, Embase, CINAHL, Cochrane Database of Systematic Reviews and screening of references, the umbrella review identified a total of 201 meta-analyses of observational research with 67 unique health outcomes and 17 meta-analyses of interventional research with nine unique outcomes.

Across various exposures (high vs low, any vs none and one extra cup a day), coffee intakes were more often associated with benefit than harm for a range of health outcomes. Evidence of a nonlinear association between consumption and some outcomes existed. [BMJ 2017;359:j5024]

Summary estimates showed that drinking three to four cups a day vs none had the largest relative risk reduction for outcomes including all-cause mortality (relative risk [RR], 0.83; 95 percent CI, 0.83–0.88), cardiovascular mortality (RR, 0.81; 0.72–0.90) and cardiovascular disease (RR, 0.85; 0.80–0.90). In addition, there was an 18-percent lower risk of incident cancer (RR, 0.82; 0.74–0.89) associated with high vs low consumption. Coffee drinking also correlated with a reduced risk of several specific cancers and neurological, metabolic, and liver conditions.

Adequate adjustment for smoking largely reversed harmful associations, except in pregnancy, where high vs low/no consumption correlated with low birth weight (odds ratio [OR], 1.31; 1.03–1.67), preterm birth in the first (OR, 1.22; 1.00–1.49) and second (OR, 1.12; 1.02–1.22) trimester, and pregnancy loss (OR, 1.46–1.99). An association also existed between coffee intake and fracture risk in women but not in men.

“Overall, there is no consistent evidence of harmful associations between coffee consumption and health outcomes, except for those related to pregnancy and for risk of fracture in women,” researchers said. “After adjustment for smoking, consumption in pregnancy seems to be associated with harmful outcomes related to low birth weight, preterm birth and pregnancy loss. [PLoS One 2015;10:e0132334; Am J Clin Nutr 2010;92:1120-1132; Int J Gynaecol Obstet 2015;130:116-122]

Containing a complex mixture of bioactive compounds, coffee has been shown to contribute a sizable proportion of daily intake of dietary antioxidant, which is greater than tea, fruit and vegetables. Its most abundant antioxidant, chlorogenic acid, gets degraded by roasting, but alternative antioxidant organic compounds are formed. [J Nutr 2004;134:562-567; J Agric Food Chem 2015;63:1996-2005]

“Caffeine also has significant antioxidant effects. The diterpenes, cafestol and kahweol, induce enzymes involved in carcinogen detoxification and stimulation of intracellular antioxidant defence, contributing towards an anticarcinogenic effect,” researchers said. [Food Chem Toxicol 2002;40:1155-1163]

“These antioxidant and anti-inflammatory effects are also likely to be responsible for the mechanism behind the beneficial associations between coffee consumption and liver fibrosis, cirrhosis, and liver cancer that our umbrella review found had the greatest magnitude of effect compared with other outcomes,” they added. [Nutrients 2017;9:85]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
2 days ago
There appears to be a high rate of emergency department (ED) admission for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), with patients having significant in-hospital mortality, according to data from the *AANZDEM study. Furthermore, compliance with evidence-based treatments in the ED is suboptimal.
Tristan Manalac, 6 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
Pearl Toh, 3 days ago
Patients with inflammatory bowel disease (IBD) who had primary nonresponse to an anti-tumour necrosis factor (TNF) agent ─ or inadequate response to the initial loading doses ─ were less likely to respond to second-line biologics compared with those who had secondary loss of response (LOR) or intolerance to the primary therapy, according to a systematic review and meta-analysis presented at the Crohn's & Colitis Congress (CCC) 2018 held recently in Las Vegas, Nevada, US.
Tristan Manalac, 16 Feb 2018
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.